Sentinel lymphadenectomy for circumscribed cutaneous T-cell lymphoma

Dermatologic Surgery

Volumn 30, Issue 6, 2004, Pages 952-956

  Wang, Chun Hua ^a   Nien, Hsiao Ching ^a   Hou, Ming Feng ^a   Chen, Gwo Shing ^a   Cheng, Shih Tsung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD30 ANTIGEN; GALLIUM 67; TECHNETIUM SULFUR COLLOID TC 99M; TUMOR MARKER;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; SKIN BIOPSY;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEG; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOMA, T-CELL, CUTANEOUS; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 2942688149     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2004.30270.x     Document Type: Article

References (26)

1. William R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma Study Group of the European organization research and treatment of cancer. Blood 1997;90:354-71.
2. Weinstock MA, Horn JW. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA 1988;260: 42-6.
3. Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European multicenter study on 47 cases. Cancer 1993;71:2097-104.
4. Krishnan J, Tomaszewski MM, Kao GF. Primary cutaneous CD30-positive anaplastic large cell lymphoma: report of 27 cases. J Cutan Pathol 1993;20:193-202.
5. Banerjee SS, Heald J, Harris M. Twelve cases of Ki-1 positive anaplastic large cell lymphoma of the skin. J Clin Pathol 1991;44: 119-25.
6. Beljaards RC, Meijer CJ, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression of primary cutaneous large-cell lymphoma of T-cell origin: a clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989;135:1169-78.
7. Paulli M, Bert E, Rosso R, et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin-clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J Clin Oncol 1996;13: 1343-54.
8. Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 2000;95:3653-61.
9. Artemi P, Wong DA, Mann S, et al. CD30 (Ki-1)-positive primary cutaneous T-cell lymphoma: report of spontaneous resolution. Australas J Dermatol 1997;38:206-8.
10. Stenier C, Bourlond A, Humblet Y. Ki-1 anaplastic primary cutaneous large-cell lymphoma. Dermatology 1995;190:332-4.
11. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.
12. Sim FH, Nelson TE, Pritchard DJ. Malignant melanoma: Maya Clinic experience. Mayo Clin Proc 1997;72:565-9.
13. Lan CC, Hou MF, Cheng ST, et al. First report of acral lentiginous melanoma treated according to result of sentinel lymph node biopsy in Taiwan. Dermatol Sinica 2001;19:282.
14. Starz H, Balda BR, Bachter D, et al. Secondary lymph mode involvement from primary cutaneous large B-cell lymphoma of the leg. Cancer 1999;85:199-207.
15. Noah KW, Monica MB, David SB. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000;43:483-8.
16. Robert EM, Nader IK, Ddayalan C. History, present status and future of sentinel lymph node biopsy in breast cancer. Acta Oncol 2000;39:265-8.
17. Lee LQ, Pu C, Cruse W. Lymphatic mapping sentinel lymph node biopsy for nonmelanoma skin cancers. Radioguided Surg 1999;8: 527-39.
18. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1997;39:456-66.
19. Choot A, Kaserer K, Augustin I, et al. Ki-1 positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol 1990;14:439-48.
20. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for the early stage melanoma. Arch Surg 1992;127:392-9.
21. Kaudewitz P, Stein H, Dallenbach F. Primary and secondary Ki-1 + (CD30+) anaplastic large cell lymphomas: morphologic, immunohistologic, and clinical-characteristics. Am J Pathol 1989;135: 359-67.
22. Headington JT, Roth MS, Ginsburg D, et al. T-cell receptor gene rearrangement in regressing atypical histiocytosis. Arch Dermatol 1987;123:1183-7.
23. Headington JT, Roth MS, Schinitzer B. Regressing atypical histiocytosis. Semin Diag Pathol 1987;4:28-37.
24. Albertini JJ, Cruse W, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
25. Reintengen D, Cruse CW. The orderly progression of melanoma nodal metastasis. Ann Surg 1994;200:759-67.
26. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44:570-82.